CNS Pharma (@cns_pharma) header
CNS Pharma (@cns_pharma) profile picture

CNS Pharmaceuticals is a biotechnology company focused on developing innovative therapies for serious diseases in neurology and oncology.

Houston, TX
Joined September 2017
Photo by CNS Pharma (@cns_pharma)Photo by CNS Pharma (@cns_pharma)Photo by CNS Pharma (@cns_pharma)Photo by CNS Pharma (@cns_pharma)Photo by CNS Pharma (@cns_pharma)Photo by CNS Pharma (@cns_pharma)Photo by CNS Pharma (@cns_pharma)Photo by CNS Pharma (@cns_pharma)Photo by CNS Pharma (@cns_pharma)Photo by CNS Pharma (@cns_pharma)
Progress begins with a commitment to making a difference. At $CNSP, that commitment drives our dedication to advancing innovative science, exploring new therapeutic approaches and working toward a future with more possibilities for patients. #Oncology #Biotech
98
CNS Pharmaceuticals Reports Third Quarter 2026 Financial Results and Highlights Progress in Establishing Transformative Therapeutic Pipeline bit.ly/4jkdtl3 #CNSP
94
Want to follow along on our journey? Sign up for our email alerts and never miss an update on what's ahead at CNS Pharmaceuticals. bit.ly/4o4o0Sb $CNSP #Oncology #Biotech #HealthcareInnovation
102
Stay up to date with $CNSP. Sign up for email alerts to receive the latest company news, press releases and updates. Sign up: bit.ly/4o4o0Sb #Biotech
203
A disciplined diligence process is key when evaluating new opportunities. $CNSP Chief Business Officer Dylan Wenke shares how the team assesses potential programs, focusing on clinical impact, commercial viability and risk as opportunities move through technical diligence.
250
#InCaseYouMissedIt CNS Pharmaceuticals Chief Business Officer, Dylan Wenke, joined Virtual Investor for a “What This Means” segment discussing the Company’s recent asset research and what it could mean for $CNSP moving forward. Watch here: vimeo.com/1222840808/9bb3667… #Biotech
1
347
Follow the progress at CNS Pharmaceuticals. Subscribe to our email alerts to receive company announcements, clinical and corporate updates, and other important news as it happens. Sign up: bit.ly/4o4o0Sb $CNSP #Biotech
225
$CNSP Chief Business Officer, Dylan Wenke, joins Virtual Investor’s “What This Means” series to discuss the Company’s business development strategy as it builds an oncology or neurology pipeline with best-in-class potential. 🔗 vimeo.com/1222840808/9bb3667… @cns_pharma
1
1
300
CNS Pharmaceuticals Details Business Development Strategy Driving Its Next Phase of Growth Chief Business Officer, Dylan Wenke, Participates in Virtual Investor “What This Means” Segment Access the segment here: bit.ly/3GplqoB bit.ly/4xC08cE $CNSP
236
Virtual Investor Launches "Why Now" On-Demand Conference Featuring Public Company CEOs Nine CEOs. Nine investment stories. 60 seconds each to answer the question that matters most to investors: Why now? Access the Conference Here: virtualinvestorco.com/why-no… $AIM $AKTX $CNSP $DARE $NVNO $ERNA $GRI $MBRX $OTLK @AimImmuno @AkariTX @cns_pharma @DareBioscience @enVVenoMedical @ErnexaTx @GRI_BIO @moleculinbio @OutlookTx
6
7
724
CNS Pharmaceuticals Participates in the Virtual Investor "Why Now" On-Demand Conference Video now available here: bit.ly/4y59L3d bit.ly/46mzW9U $CNSP #VirtualInvestor @InvestorVirtual
1
2
260
Every breakthrough starts with a belief that better is possible. At CNS Pharmaceuticals, that belief fuels our commitment to advancing innovative science and exploring new therapeutic possibilities for the future. $CNSP #Oncology #Neurology #Biotech #HealthcareInnovation
207
CNS Pharmaceuticals Reports Second Quarter 2026 Results, Highlighting Strengthened Balance Sheet and Accelerated Execution of Strategic Transformation bit.ly/4g6kljo $CNSP #oncology #neurology
1
239
News happens fast. Stay informed. Subscribe to CNS Pharmaceuticals email alerts for the latest company news, clinical updates, investor announcements and more. Sign up: bit.ly/4o4o0Sb $CNSP #Oncology #Neurology #Biotech #HealthcareInnovation
226
CEO Rami Levin will be attending the Canaccord Genuity 46th Annual Growth Conference in Boston, MA, August 11-13. To learn more about $CNSP and its pipeline, please contact [email protected] to schedule a meeting. We look forward to connecting with you in Boston. #Oncology
1
248
Want the latest updates from $CNSP delivered directly to your inbox? Sign up for email alerts to stay informed on company news, milestones and upcoming announcements. Subscribe here: bit.ly/4o4o0Sb #Oncology #Neurology
202
At $CNSP, we are focused on advancing differentiated therapeutic opportunities that address significant unmet medical needs. Guided by an experienced leadership team and a disciplined strategy, we remain committed to improving patient outcomes and creating long-term value.
2
185
In the latest CEO Connect segment, $CNSP CEO Rami Levin discusses the Company's strategic transformation, recent $22.5 million financing and efforts to build a differentiated pipeline focused on high-value opportunities. See here: vimeo.com/1193965352/6cf0543… #Oncology #Neurology
1
1
222
As America celebrates 250 years of independence, we wish everyone a safe and happy Fourth of July. From all of us here at $CNSP, have a wonderful holiday. #IndependenceDay
1
150